menu

QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

distribution
Brazilians flock to pharmacies: How healthcare companies can bolster sales by embracing this shifting shopper trend
Filtered by 'EMA' ×
Liz Allen
Why the EMA is updating its Phase I one safety guidance for volunteers, and how sponsors should respond.
Read More
Anke van Engen
The adaptive pathway offers a number of real benefits, but sponsors must be prepared to face challenges in demonstrating the safety and effectiveness of treatments brought to market through this approach.
Read More
Chris Bamford
How Regulation 536/2014 will impact the way developers conduct research in the EU.
Read More
Paul Kelly
How a new regulatory update will change the way companies file safety reports – and what to do to prepare.
Read More
Jeremy Broadis
Obtaining regional and local market access in the age of health technology assessments.
Read More
DeanSummerfield
Exploring the challenges HTA bodies face keeping pace with fast track approval paths and value as defined by the patient.
Read More
Robin Douglas
A centralized approach to monitoring has been shown to improve data quality and patient safety while lessening the burden on-site staff.
Read More
StellaBlackburn
What we learned from conducting an observational study of pregnant women throughout their pregnancies.
Read More
Jennifer Christian
How to improve collection of patient reported data, and how it can increase the value of new treatments.
Read More
Anke van Engen
Global health technology assessment organizations are looking for specific patient populations where the product shows greatest added benefits.
Read More